When taken, Trulicity stimulates the GLP-1 receptors in the body, which leads to increased insulin secretion, reduced glucagon secretion (which lowers blood sugar levels), slowed gastric emptying, and increased feelings of fullness
Experimental data indicates that the peptide fragment interacts with the 3-adrenergic pathway, which mediates the breakdown of triglycerides into free fatty acids and glycerol within adipose tissue
Primary source for contraindications and warnings, used for the FAQ in Section 10
SARS-CoV-2 may have direct access to brain areas for the development of PD, according to neuropathological investigations utilizing immunostaining of -synuclein aggregates that imply that PD starts in either the olfactory or intestinal neurons and progresses to the brain
Focus on what you eat, as good choices can help your overall well-being and even help with weight management while you take this medicine